[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Natural immunity in Portugal", "description": "Rise of natural acquired immunity\n\nGet additional scientific background from John\u2019s free text books,\n\nhttp://159.69.48.3/\n\n(you will need to cut and paste this link into your browser)\n\nRisk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants\n\nhttps://www.nejm.org/doi/full/10.1056/NEJMc2209479?query=TOC&cid=NEJM%20eToc,%20September%201,%202022%20DM1402792_NEJM_Non_Subscriber&bid=1141953912\n\nhttps://www.nejm.org/doi/suppl/10.1056/NEJMc2209479/suppl_file/nejmc2209479_appendix.pdf\n\nOmicron subvariants, BA.1 and BA.2, displaced by BA.5 in many countries\n\nGreater transmissibility\n\nPartial evasion of BA.1- and BA.2-induced immunity\n\nPortugal, one of the first countries affected by a BA.5 predominance\n\nN = 9,307,996\n\nAll Portuguese residents aged 12 years and older, (National Census 2021) \n\nUninfected people in June 1st 2022 was 5, 328, 287, (57% of the Portuguese population over 12)\n \n(PCR tests and rapid antigen tests to diagnose cases) \n\nPresence of undocumented infections among the \u201cuninfected\u201d group of individuals \n\n29.2% of infections were not notified\n\n(based on the seroprevalence of SARS-CoV-2 anti-N IgG in the population) \n\nNational coronavirus disease 2019 registry (SINAVE)\n\n(all reported cases in the country, regardless of clinical presentation)\n\nTo calculate the risk of BA.5 infection after documented infection with past variants, \n\nincluding BA.1 and BA.2\n\nTimes when different variants represented more than 90% of the isolates\n\nTo calculate their infection risk during the period of BA.5 dominance\n\nPooled BA.1 and BA.2 (slow transition between the two subvariants)\n\nComparator group\n\nPopulation that did not have any documented infection before BA.5 dominance (June 1, 2022)\n\nResults\n\nWuhan-Hu-1  55.7%\n\nAlpha   58.8%\n\nDelta   64.5%\n\nBA.1 / BA.2 7 6.8%\n\nWe found that previous SARS-CoV-2 infection had a protective effect against BA.5 infection\n\nProtection was maximal for previous infection with BA.1 or BA.2 (not suprising)\n\nContext\n\nPortugal more than 98% of the study population completed the primary vaccination series before 2022\n\nThere is a perception that the protection afforded by previous BA.1 or BA.2 infection is very low, given the high number of BA.5 infections among persons with previous BA.1 or BA.2 infection. \n\nOur data indicate that this perception is probably a consequence of the larger pool of persons with BA.1 or BA.2 infection than with infection by other subvariants, and it is not supported by the data.\n\nBreakthrough infections with the BA.5 subvariant were less likely among persons with a previous SARS-CoV-2 infection history \u2026 especially for previous BA.1 or BA.2 infection, than among uninfected persons.", "link": "https://www.youtube.com/watch?v=SN7cX_linEA", "date_published": "2022-09-01 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]